BindingDB Entry 50015483: Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors.

Name: BindingDB Entry 50015483: Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors.
Creator: BindingDB
Keywords: ADAM12, ADAM17, Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10), and Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9), Department of Life Science and National Research Laboratory of Proteolysis, Affinity, 3. Good health

Research datakeyboard_double_arrow_right Dataset 01 Jan 2009 English Publisher:BindingDB

Authors: BindingDB;

doi: 10.7270/q29z94dh

BindingDB Entry 50015483: Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors.

- Summary
- Subjects
- Related research
  (10)
- Metrics

tips_and_updates
Recommended

Abstract

Small molecule binding data for protein ADAM12, ADAM17, Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10), and Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9), Uniprot O14672, O43184, P78536, and Q13443

Keywords

ADAM12, ADAM17, Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10), and Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9), Department of Life Science and National Research Laboratory of Proteolysis, Affinity

10 Research products, page 1 of 1

BindingDB Entry 50031468: Discovery and SAR of hydantoin TACE inhibitors.
2010IsAmongTopNSimilarDocuments
Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors
2004IsDerivedFrom
BindingDB Entry 50047148: Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.
2017IsAmongTopNSimilarDocuments
BindingDB Entry 50030219: Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.
2010IsAmongTopNSimilarDocuments
BindingDB Entry 50043441: TBA
2014IsAmongTopNSimilarDocuments
BindingDB Entry 50033297: 2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.
2011IsAmongTopNSimilarDocuments
BindingDB Entry 50009909: Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.
2021IsAmongTopNSimilarDocuments
BindingDB Entry 50049210: Identification of novel TACE inhibitors compatible with topical application.
2019IsAmongTopNSimilarDocuments
BindingDB Entry 50031497: Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.
2010IsAmongTopNSimilarDocuments
BindingDB Entry 50032629: Novel TNF-a converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseases.
2011IsAmongTopNSimilarDocuments

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average